ID

42054

Descripción

Study documentation part: Other diseases and therapies except tumors, VTETumor02. This is a prospective, randomized, controlled, unicentric, open study on prophylactic treatment of thromboembolism with Enoxaparin in non-surgical oncology patients under systemic antineoplastic therapy. Principal Investigator Prof. Dr. Max E. Scheulen, Clinic and Polyclinic for Internal medicine (Tumor research), University Hospital of Essen, Germany. EudraCT number: 2007-002036-28, Version 0.6 vom 06.08.09.

Palabras clave

  1. 21/9/16 21/9/16 -
  2. 15/3/21 15/3/21 - Dr. rer. medic Philipp Neuhaus
Subido en

15 de marzo de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

End form: Other diseases and therapies except tumors VTETumor02 Prophylactic Treatment of Thromboembolism with Enoxaparin EudraCT number: 2007-002036-28

Other diseases and therapies except tumors

Weitere Erkrankungen und Therapien
Descripción

Weitere Erkrankungen und Therapien

Alias
UMLS CUI-1
C2359476
UMLS CUI-3
C0087111
Name der Erkrankungen/ Risikofaktoren
Descripción

concomitant disease; risk factors

Tipo de datos

text

Alias
UMLS CUI [1]
C0243087
UMLS CUI [2]
C0035648
Datum Beginn
Descripción

date Onset of illness

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0277793
Veränderung während der Studie
Descripción

Disease condition finding

Tipo de datos

text

Alias
UMLS CUI [1]
C1299555
Datum
Descripción

date Disease condition finding

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1299555
Name der Therapie/des Medikaments und Dosis
Descripción

concomitant therapy Drug dosage

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1707479
UMLS CUI [1,2]
C0870450
Datum Beginn
Descripción

therapy start date

Tipo de datos

date

Alias
UMLS CUI [1]
C3173309
Veränderung während der Studie
Descripción

Therapy change

Tipo de datos

text

Alias
UMLS CUI [1]
C3665894
Datum
Descripción

date Therapy change

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C3665894
Grund
Descripción

indication Therapy change

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C3665894

Similar models

Other diseases and therapies except tumors

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Weitere Erkrankungen und Therapien
C2359476 (UMLS CUI-1)
C0087111 (UMLS CUI-3)
concomitant disease; risk factors
Item
Name der Erkrankungen/ Risikofaktoren
text
C0243087 (UMLS CUI [1])
C0035648 (UMLS CUI [2])
date Onset of illness
Item
Datum Beginn
date
C0011008 (UMLS CUI [1,1])
C0277793 (UMLS CUI [1,2])
Item
Veränderung während der Studie
text
C1299555 (UMLS CUI [1])
Code List
Veränderung während der Studie
CL Item
keine  (0)
CL Item
neu aufgetreten (1)
CL Item
abgeklungen  (2)
CL Item
verbessert  (3)
CL Item
verschlechtert (4)
date Disease condition finding
Item
Datum
date
C0011008 (UMLS CUI [1,1])
C1299555 (UMLS CUI [1,2])
concomitant therapy Drug dosage
Item
Name der Therapie/des Medikaments und Dosis
text
C1707479 (UMLS CUI [1,1])
C0870450 (UMLS CUI [1,2])
therapy start date
Item
Datum Beginn
date
C3173309 (UMLS CUI [1])
Item
Veränderung während der Studie
text
C3665894 (UMLS CUI [1])
Code List
Veränderung während der Studie
CL Item
keine  (0)
CL Item
neu verordnet  (1)
CL Item
abgesetzt  (2)
CL Item
Dosis verringert  (3)
CL Item
Dosis erhöht (4)
date Therapy change
Item
Datum
date
C0011008 (UMLS CUI [1,1])
C3665894 (UMLS CUI [1,2])
Item
Grund
text
C0392360 (UMLS CUI [1,1])
C3665894 (UMLS CUI [1,2])
Code List
Grund
CL Item
Unwirksamkeit  (1)
CL Item
Nebenwirkungen  (2)
CL Item
Verbesserung  (3)
CL Item
Verschlechterung  (4)
CL Item
neue Begleiterkr. (5)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial